chrisvoncsefalvay/vaers-outcomes huggingface dataset:
11/13 Tired and Nauseous at first but later dizziness and headaches. Vertigo  also, because eyesight was kinda wavy. 11/15 Went to see doctor at the hospital and was given a CoVid test(negative) an antibiotic and was diagnosed with upper respiratory infection. Been homebound since but seems to be clearing up.
Giant Cell Arteritis--treatment steroid---biopsy proven--loss of sight in one eye
This spontaneous report as received from a registered nurse refers to unspecified amount of patients. On an unknown date the patients were vaccinated with improperly stored PROQUAD (merck). Administration route, date and lot number were not reported. The nurse reported that the PROQUAD (merck) was exposed to a temperature of 1.4C for 30 hours. She also reported that the PROQUAD (merck) had multiple excursions in which it was exposed to a temperature between above -15C to -10C for an unspecified amount of hours which she "believes" was due to defrost cycles. No adverse effect reported. This is one of three reports received from the same source. Additional information has been requested.
Flu-like sx; fever, muscle ache, diarrhea & cough for 5 days duration; Seen in office;
This spontaneous report was received from a nurse practitioner, via company representative, concerning an unspecified patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were unspecified by reporter. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (strength, dose number, route, anatomical location, lot number and expiration date were unspecified). On an unknown date the patient developed hives, in an unspecified location, following the administration of ZOSTAVAX. The outcome of hives was unknown. The relatedness between hives and ZOSTAVAX was not reported. Additional information has been requested.
Went for the 2nd dose, they didn't have it; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of product supply issue in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received years ago).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced product supply issue (Verbatim: Went for the 2nd dose, they didn't have it). The outcome of the product supply issue was unknown.   Additional Information: GSK Receipt Date: 15-MAR-2023 The patient had the first shingles shot years ago but every time he/she went for the second part of the first shot, they did not had it.  The patient stated that he/she guess to finally gave up and so far very fortunate. The follow-up could not be possible as no contact details were available.
Fever a few hours after vaccines given to 102.3 degree - a fine popular rash on head and upper trunk.
Fever of 102 degrees starting same night as the one dose COVID Janssen vaccine along with excrutiating headache. Took Tylenol each day of fever. Rested as headache made me very nauseas. Took Zofran for nausea. Fever lasted four days. Sever headache lasted 5 days. Lower leg cramps plus chills with sweating began on day 5.
Swollen supraclavicular lymph nodes with edema . Began 2 days after second dose.
This spontaneous report as received from an other health professional refers to patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M037770 for prophylaxis. No adverse effects were reported. Data logger was involved. This is one of several reports received from the same reporter. Additional information is not expected.; Sender's Comments: US-009507513-1708USA005844: US-009507513-1708USA005822:
Delayed Moderate. Myalgias several hours later,  worsened myalgias in the Evening, Shivering, "burning up" no fever, headache, back pain, palpitations, left axillary lymph node (peach pit size) bilateral  inguinal pain  next day. Symptoms improved
Developed degenerative neurologic disease starting symptoms in May of 2022 and progressing to a comatose state in July, 2022. Currently in a comatose state.
5 MINUTES POST INJECTION : TONGUE STARTS TINGLING . SWEELING GLANDS IN THROAT . TOOK DIPHENYDRAMINE 10MINUTES LATER : BP 143/90 - THROAT STILL SWOLLEN - ARM TINGLING MBUT TONGUE IS BETTER
Fatigue; Chills; Muscle pain; Joint pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A, 010M20A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient experienced FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache). At the time of the report, FATIGUE (Fatigue), CHILLS (Chills), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown.            No concomitant medications were provided.  Patient was taking other medication (unspecified).
On 3/20 I exp body aches, itching around injection site. Then on 3/21 I began having a headache still exp it as of 3/25 not pleasing at all. I started running low grade fever on Wed 99.3 contacted my provider was told to take Tylenol. I'm not sure if the headache is due to vaccine or lack of me being able to receive Botox injection.I was told to wait 14 days after vaccine for the injection.
Pt arrives with confusion, syncope, and fall 2 days ago along with vomiting and diarrhea.
On Feb. 26, the day of the 2nd vaccination, became extremely tired with a headache and strong facial flushing. The tiredness and flushing lasted through Feb. 28. Took Advil for the headache and took naps throughout the next two days.  On Feb 27 the left arm was sore at injection site (no soreness occurred after the first vaccination on 01/30/2021) and a rash developed around injection site and spread down the arm in an elongated egg shape. The rash was bumpy and itchy. The rash has disappeared as of 03/04/2021, 9:00 A.M.
Mass on Kidney; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of RENAL MASS (Mass on Kidney) in a 77-year-old female patient who received mRNA-1273 for COVID-19 vaccination.     The patient's past medical history included Thyrotoxicosis with goiter (Thyrotoxicosis with diffuse goiter without thyrotoxic crisis). Concurrent medical conditions included Sulfonamide allergy (Allergic to sulfa antibiotics) and Chronic lymphocytic leukemia (Chronic Lymphocytic Leukemia of B cell type not having achieved remission). Concomitant products included IBRUTINIB (IMBRUVICA) from 10-Dec-2016 to 23-May-2018 for Chronic lymphocytic leukemia, PARACETAMOL (TYLENOL), METHIMAZOLE, VITAMIN D NOS, ATORVASTATIN CALCIUM, GABAPENTIN, LIDOCAINE, METOPROLOL TARTRATE, OXYCODONE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and VITAMIN C [ASCORBIC ACID] for an unknown indication.   On an unknown date, the patient received first dose of mRNA-1273 (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RENAL MASS (Mass on Kidney) (seriousness criteria hospitalization). At the time of the report, RENAL MASS (Mass on Kidney) outcome was unknown.        For mRNA-1273 (Intramuscular), the reporter did not provide any causality assessments.   The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.  Based on current available information and the temporal Association between product use and the start date of the events a causal relationship is unlikely. Very little information is available for review. Further information has been requested.; Sender's Comments: Based on current available information and the temporal Association between product use and the start date of the events a causal relationship is unlikely. Very little information is available for review. Further information has been requested.
This case was reported by a other health professional via sales rep an described the occurrence of swelling arm in a patient who received MENVEO (batch number M15098, expiry date unknown). On 30th September 2016, the patient received MENVEO. On 20th September 2016, less than a day after receiving MENVEO, the patient experienced swelling arm. On an unknown date, the outcome of the swelling arm was unknown. It was unknown if the reporter considered the swelling arm to be related to MENVEO. Additional details were provided as follows: The patient received vaccine on an unknown arm.
None known. Patient was given double dose of Polio by mistake, reported to MD's local county MD nurse.
Tongue, lips swelling, hands and wrists (fingers) numb and tingling.  Vaccine administered 1:38pm Benadryl 50mg PO administered 1:50pm Epi pen given at 2:10pm
I was sick for like 3 days after both shots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34-year-old male patient received BNT162b2 (BNT162B2), on 09Jun2021 as dose 1, single (Lot number: EW0187) at the age of 34 years, in arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: FLUOXETINE; HYDROXYZINE HCL. The following information was reported: ILLNESS (non-serious) with onset Jun2021, outcome "unknown", described as "I was sick for like 3 days after both shots".  Additional information: Patient stated he took 2 Pfizer shots, got an initial Pfizer shot and then got a booster shot and had never felt good again after taking those shots. when patient took the shots, First he was super sick, by the way he was sick for like 3 days after both shots and then when, so the first shot was on 09Jun2021 (09Jun2021), the second shot was on 30Jun2021 and have never felt like this, he have like heart palpitation. He has just never, he has never felt the same.  When they gave him the shot, he was sick initially and then kind of, got over the like because he could not leave out of the bed and then it just, everything just started to tear him, he was off on one level and then ever since he has had the shots, his heart has declined tremendously. He has not gone to the Doctor in years.
Presented to ED with continued right shoulder pain (site of injection), that is warm, swollen and tender. Also with Temp 102F.
When I got home to take a shower, I noticed a small rash under the arm of where I got the injection. It was a little itchy. I took benedryl. The only other symptoms I had was joint achiness and tiredness.
I got home and took a shower after getting out I was receiving streaks in my vision mostly in my left eye. It didn't resolve until about half hour and I had a repeat of this event two weeks ago around June 02,2021. I had dilation of the pupils.
I60.9 - Nontraumatic subarachnoid hemorrhage, unspecified I62.00 - Nontraumatic subdural hemorrhage, unspecified G61.0 - Guillain-Barre syndrome G61.0 - Acute inflammatory demyelinating polyneuropathy
Fever; Chills; Nausea; Dizziness; Stomach Pain; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), DIZZINESS (Dizziness) and ABDOMINAL PAIN UPPER (Stomach Pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), DIZZINESS (Dizziness) and ABDOMINAL PAIN UPPER (Stomach Pain). At the time of the report, PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), DIZZINESS (Dizziness) and ABDOMINAL PAIN UPPER (Stomach Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included Celebrex. No relevant concomitant medications were reported.   Reporter did not allow further contact
Woke at 2:30 AM bathed in sweat, intense,severe pain neck, shoulders, hands, feet,  pelvis. Profound weakness, difficulty walking. Incontinence, vomiting. Shortness of breath, wheezing, confusion
chills; muscle pain; slight headache; have been in bed all day.; slight dizziness; mouth is dry; coughing; feel a little bit warm; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (slight dizziness), DRY MOUTH (mouth is dry), COUGH (coughing), FEELING HOT (feel a little bit warm) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011D21A and 006C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Viral infection. Concomitant products included LOSARTAN and METOPROLOL for Blood pressure high.   On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced DIZZINESS (slight dizziness), DRY MOUTH (mouth is dry), COUGH (coughing), FEELING HOT (feel a little bit warm), MYALGIA (muscle pain), HEADACHE (slight headache) and FATIGUE (have been in bed all day.). On 11-Jun-2021 at 7:00 AM, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, DIZZINESS (slight dizziness), DRY MOUTH (mouth is dry), COUGH (coughing), FEELING HOT (feel a little bit warm), CHILLS (chills), MYALGIA (muscle pain), HEADACHE (slight headache) and FATIGUE (have been in bed all day.) outcome was unknown.            Concomitant medications included unspecified medicine for viral infection.
Immunization given 2-29-08; symptoms developed 3-3-08, "flu-like" with cough (green phlegm), no fever, had fatigue on 3-8-08. Seen at clinic, diagnosed with "bronchitis", given Amoxicillin.
Pt developed acute pain, redness and induration of entire lateral shoulder with urticaria locally. Pt also had chills, diaphoresis, and low grade fever resolving after 2nd day.
pt recvd Engerix-B on 9SEP91, 17OCT91, 17MAR92 & 12MAY92 pt's antibody titer results were neg (borderline);
This spontaneous report was received from a nurse via a company representative concerning her 14-year-old daughter. There was no information about the patient's medical history, drug reactions, allergies, concurrent conditions or concomitant medications to be reported. On an unspecified date in July 2018, the patient received her first dose of GARDASIL 9 (strength, dose, route, lot number and expiration date not reported) for prophylaxis. It was reported that the patient experienced Bell's palsy (facial paralysis) immediately after receiving the vaccination with GARDASIL 9. The outcome of the event was not reported. The causality between GARDASIL 9 and the event was not reported. Upon internal review, the event facial paralysis was determined to be medically significant.
On the night of 1/9/08 the patient developed a red inflammed prurtic rash on the left upper arm. On exam, 1/10/08, the patient presented with an erythematous rash slight indurated on the left upper deltoid with no tenderness to touch noted and no heat. The patient was afebrile on the day of the exam. The patient was prescribed Benadryl 6.25 mg q8h prn for induration and pruritis on the left upper arm and hydrocortisone 2.5% topically BID prn to rash while present.
rotator cuff injury; This spontaneous case was reported by a consumer and describes the occurrence of ROTATOR CUFF SYNDROME (rotator cuff injury) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.  Concurrent medical conditions included Type 2 diabetes mellitus (Recent change in status: no difference) since 1996 and Heart rate abnormal (Concomitantly, took 25 mg metoprolol extended-release twice a day to help control heart rate XL). Concomitant products included METOPROLOL for Heart rate abnormal, INSULIN GLARGINE (LANTUS) and CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]) for an unknown indication.  On 08-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ROTATOR CUFF SYNDROME (rotator cuff injury). The patient was treated with HYDROCORTISONE on 07-Mar-2022 at an unspecified dose and frequency. At the time of the report, ROTATOR CUFF SYNDROME (rotator cuff injury) had not resolved.  The patient had no allergies. The patient was never diagnosed with COVID positive. There were no other vaccines that the patient received within 1 month prior to Moderna COVID-19 vaccine.  The patient had a lot of shoulder problems with his rotator cuff injury. The patient received hydrocortisone shots in his shoulder for rotator cuff injury to stop the pain.   As per the patient, the event was not related to the vaccine.   This case was linked to MOD-2021-033647 (Patient Link).
aura seizure; aura seizure; fatigue; headache; heart palpitations; aphasia; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (aura seizure) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MARIJUANA for an unknown indication.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced PALPITATIONS (heart palpitations), APHASIA (aphasia), FATIGUE (fatigue) and HEADACHE (headache). On 30-Apr-2021, the patient experienced SEIZURE (aura seizure) (seriousness criterion medically significant) and AURA (aura seizure). At the time of the report, SEIZURE (aura seizure), PALPITATIONS (heart palpitations), APHASIA (aphasia), AURA (aura seizure), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No medical history was provided by the reporter.  Treatment included Aspirin for headache.  Company comment:Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the previous history of previous injury, is a confounder.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, the previous history of previous injury, is a confounder.
Immediately after receiving vaccine, customer appeared to slouch over and I held his head and talked to him as I was unsure if he was just joking in front of his family.  He then sat up and indicated he did not remember slouching.  I explained to him that his blood pressure probably just went too low and asked him to continue breathing and try to put his head between his legs. He seemed fairly alert but a few seconds later, experienced some body jerking and I asked his father to call EMS, which he did.  Customer then seemed to be in a semi alert state and started sweating profusely.  I continued talking to him and watched for a fall until the EMS arrived.  EMS triaged him and took him from the store.  EMS reported systolic blood pressure unmeasurable upon arrival and around 70 at time of taking him from location (approximate numbers)
Rash and lump to site fever 103.4.  Rash all over left leg.
Patient had swelling and redness throughout her upper arm. She reported it was warm to the touch and also reported a low grade fever (around 99 degrees).
Tested positive for Covid 19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for Covid 19) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 05AR21A and 032M20A) for COVID-19 prophylaxis.     Allergies: No No medical history was reported by the reporter.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], LISINOPRIL, SIMVASTATIN and ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jan-2022, the patient experienced COVID-19 (Tested positive for Covid 19). At the time of the report, COVID-19 (Tested positive for Covid 19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2022, SARS-CoV-2 test: (Positive) Positive for COVID-19 Omicron variant.         The patient had symptoms of burning feeling in her throat, chills, A little headache and body ache. Patient reported that she did not take any medication for these symptoms.  Company Comment: This spontaneous case reported by a patient concerns a 64-year-old female patient, obese with a body mass index of 30.8, and with concomitant intake of aspirin, lisinopril and simvastatin, who experienced unexpected, non-serious AESI Covid19, after vaccination with 2 doses of mRNA-1273.  She received her first dose of mRNA-1273 around 10 months prior; the date of vaccination of the second dose was unknown.  The patient had symptoms of chills, body ache, headache and burning feeling in the throat.  She did not take any medications for these symptoms.  The ongoing Covid19 pandemic could be a contributory factor.  Obesity and intake of aspirin, lisinopril and simvastatin indicative of possible heart disease, hypertension and dyslipidemia could also be confounding factors.  The benefit risk relationship of mRNA-1273 is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This spontaneous case reported by a patient concerns a 64-year-old female patient, obese with a body mass index of 30.8, and with concomitant intake of aspirin, lisinopril and simvastatin, who experienced unexpected, non-serious AESI Covid19, after vaccination with 2 doses of mRNA-1273.  She received her first dose of mRNA-1273 around 10 months prior; the date of vaccination of the second dose was unknown.  The patient had symptoms of chills, body ache, headache and burning feeling in the throat.  She did not take any medications for these symptoms.  The ongoing Covid19 pandemic could be a contributory factor.  Obesity and intake of aspirin, lisinopril and simvastatin indicative of possible heart disease, hypertension and dyslipidemia could also be confounding factors.  The benefit risk relationship of mRNA-1273 is not affected by this report.
Hospitalized dyspnea, coughing and weakness.  Pneumonia with ground glass opacities.  Remdesivir, dexamethasone